Prostate cancer antigen 3 (PCA3), the highly prostate-specific lncRNA overexpressed in more than 95% of primary prostate tumors, was developed as a urine test for the supplementary diagnosis of prostate cancer (PCa) [4]. The gene discussed is PCA3; the disease is prostate neoplasm.